Legrand Pharma
Pharmaceutical growth and sales
- B2B
About Legrand Pharma
A leading pharmaceutical company in Latin America, recognized for its growth, quality medications, and commitment to transparent actions and partnerships in the Brazilian market
Key facts
- Industry
- Pharmaceutical Manufacturing
- Company size
- 251–1,000 employees
- Headquarters
- Campinas, São Paulo, Brazil
- Revenue
- $20.8M – $164MTamtam estimate
- Website
- legrandpharma.com.br
Legrand Pharma in the news
- Kepler Cheuvreux eleva Legrand para Compra devido a margens resilientes
Kepler Cheuvreux upgraded Legrand to Buy, citing resilient margins and strong growth in data centers supporting solid outlook through 2026.
- Legrand SA (LGRDY) Q3 2025 Earnings Call Highlights: Strong Data
Legrand showed strong sales and margin growth driven by data centers, confirmed 2025 targets, and expanded via acquisitions despite some regional market softness.
- Legrand cai 11% com desaceleração na América do Norte afetando resultados do 3º tri
Legrand's Q3 results fell short due to North American growth slowdown and margin pressure, causing an 11% share drop and cautious full-year outlook.
Legrand Pharma at a glance
Legrand Pharma is a B2B company in the Pharmaceutical Manufacturing industry, headquartered in Campinas, São Paulo, Brazil.
Legrand Pharma has 251–1,000 employees.
Legrand Pharma's revenue is $20.8M – $164M (Tamtam estimate).
Frequently asked questions about Legrand Pharma
What is Legrand Pharma's revenue?
Tamtam estimates Legrand Pharma's annual revenue at $20.8M – $164M.
How many employees does Legrand Pharma have?
Legrand Pharma has 251–1,000 employees.
Where is Legrand Pharma headquartered?
Legrand Pharma is headquartered in Campinas, São Paulo, Brazil.
Selling to companies like Legrand Pharma?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies